Skip to main content
Article thumbnail
Location of Repository

Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia

By Julie Gorchynski and Jeri K Rose


Methicillin-resistant Staphylococcus aureus (MRSA) infections have grown to epidemic proportions in the United States. With the development of increasing drug resistance of MRSA to traditional antimicrobials, there has been a search for a more effective antibiotic treatment. Linezolid is one of the most effective oral medications used for outpatient treatment of MRSA infections. We present a case of pancytopenia after outpatient treatment with linezolid. Myelosuppression is a rare but serious side effect of linezolid of which emergency physicians need to be aware in order to provide early intervention

Topics: Infectious Disease
Publisher: Department of Emergency Medicine, University of California, Irvine School of Medicine
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2006). Current antimicrobial 1. resistance profiles among methicillin-resistant Staphylococcus aureus encountered in the outpatient setting. Diagn Microbiol Infect Dis.
  2. (2005). Disease Control and Prevention. 4. CommunityAssociated MRSA Information for Clinicians.
  3. (2006). Lancet Infect Dis.
  4. (2004). Reversal of linezolid-associated 6. cytopenias, but not peripheral neuropathy, by administration of vitamin B6.
  5. (2007). Staphylococcus aureus: Management Principles and Selection of Antibiotic Therapy. Dermatol Clin.
  6. (2007). Zyvox prescribing information.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.